A Huge Hepatocellular Carcinoma With Major Arteriovenous Shunt Successfully Treated With Chemoembolization Plus Lenvatinib Therapy Followed by Radiotherapy
For patients who are contraindicative for immune checkpoint inhibitors or major liver resection, TACE plus lenvatinib followed by radiotherapy is safe and potentially an optimal treatment option.
Authors
- Yoshiyuki Fukugawa
- Toshiro Masuda (ORCID: https://orcid.org/0000-0003-4306-4277)
- Toshihiko Motohara
- Kazuaki Yoshizato
- Toru Beppu
- Ryuichi Karashima (ORCID: https://orcid.org/0000-0002-8532-3938)
- HIDEAKI MIYAMOTO
- Yasunori Nagayama (ORCID: https://orcid.org/0000-0003-3280-7346)
- Takatoshi Ishiko
- Eri Oda
- Yuki Adachi
Institutions
- Yamato University (JP)
- Sunagawa City Medical Center (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.21873/anticanres.17558
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00